跳至主要内容
临床试验/IRCT20180421039376N1
IRCT20180421039376N1已完成3 期

Escitalopram efficacy on quality of life and prevention of depression in breast cancer patient with mastectomy

Esfahan University of Medical Sciences0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
Female

入选标准

  • Women 18-65 y/o
  • Diagnosed with breast cancer stage I,II,IIIa and undergone modified radical mostectomy with or without chemothrapy and radiotherapy
  • Consciously agreement
  • Having at least literacy of writing and reading

排除标准

  • Pregnancy and lactation
  • History of conductive heart diseases
  • Severe renal failure
  • Moderate to severe hepatic failure
  • History of SSRI drugs reactions and sensitivity
  • Suffering from depression mood disorders, bipolar disorders or psychotic disorders based on DSM V criteria
  • Any condition limiting life expectancy
  • Any Use of anti depression or anti anxiety drugs since 2 weeks before the study
  • Any precipitation on group or individual psychotherapy sessions since 4 weeks before the study
  • Suffering from any speech disorders
  • Suffering from uncontrolled pain on the beginning of the study
  • Having suicide plans or thoughts on the beginning of the study

研究者

相似试验